<p>A and B, injection sites of NOD/SCID mice at 6 weeks after inoculation with freshly sorted SP or NSP cells. Tumors are observed in all mice inoculated with 2,000 SP cells, but not in mice inoculated with 2,000 NSP cells. C and D, Pathological examination shows typical renal cell carcinoma in mice inoculated with either 2,000 SP cells or 200,000 NSP cells.</p
<p>(A) 1×10<sup>3</sup> ABCG2<sup>hi</sup> SP and ABCG2<sup>low</sup> NSP sorted RT112 cells were su...
<p>Evaluation of the incidence of tumors in NOD/SCID mice implanted with different numbers of BCSCs ...
<p>(A) 1×10<sup>6</sup> ES cells (MPI-II) or <i>in vitro</i> differentiated cells (day 14 of differe...
<p>(A) Injection sites of nonobese diabetic (NOD)/severe combined immunodeficiency (SCID) mice. Hema...
<p>(A) Formation of tumors following injection of CD24+ cells. Groups of six NOD/SCID mice were inje...
<p>A, NOD/SCID mice were inoculated with 5,000 second-generation SP cells from a tumor formed with 2...
<p>(<b>A</b>) Formation of tumors following injection of CD24<sup>+</sup> cells. Groups of six NOD/S...
<p>(<b>A</b>) Formation of tumors following injection of CD24<sup>+</sup> cells. Groups of six NOD/S...
<p>N/A, not applied. All data are presented as the number of mice developed tumors/the number of mic...
<p>Abbreviations: SP, side population; NSP, non-SP; NOD, nonobese diabetic; SCID, severe combined im...
<p>Summary of tumor incidence in OPN<sup>+/+</sup> and OPN<sup>−/−</sup> mice upon injecting with SP...
<p>A, Table presentation of the tumorigenic potential of H460 SP and non-SP cells. Three parameters ...
<p>A, Tumor incidence from 3 experiments. Equal numbers of sex matched SCID mice were injected s.c. ...
<p>NOD/SCID mice were subcutaneously injected with hPSC, ihPSC, and Hela cells (8 x 10<sup>6</sup> c...
<p>SCC-13 spheroid- and monolayer-derived cells were injected at 100 to 100,000 cells per each of tw...
<p>(A) 1×10<sup>3</sup> ABCG2<sup>hi</sup> SP and ABCG2<sup>low</sup> NSP sorted RT112 cells were su...
<p>Evaluation of the incidence of tumors in NOD/SCID mice implanted with different numbers of BCSCs ...
<p>(A) 1×10<sup>6</sup> ES cells (MPI-II) or <i>in vitro</i> differentiated cells (day 14 of differe...
<p>(A) Injection sites of nonobese diabetic (NOD)/severe combined immunodeficiency (SCID) mice. Hema...
<p>(A) Formation of tumors following injection of CD24+ cells. Groups of six NOD/SCID mice were inje...
<p>A, NOD/SCID mice were inoculated with 5,000 second-generation SP cells from a tumor formed with 2...
<p>(<b>A</b>) Formation of tumors following injection of CD24<sup>+</sup> cells. Groups of six NOD/S...
<p>(<b>A</b>) Formation of tumors following injection of CD24<sup>+</sup> cells. Groups of six NOD/S...
<p>N/A, not applied. All data are presented as the number of mice developed tumors/the number of mic...
<p>Abbreviations: SP, side population; NSP, non-SP; NOD, nonobese diabetic; SCID, severe combined im...
<p>Summary of tumor incidence in OPN<sup>+/+</sup> and OPN<sup>−/−</sup> mice upon injecting with SP...
<p>A, Table presentation of the tumorigenic potential of H460 SP and non-SP cells. Three parameters ...
<p>A, Tumor incidence from 3 experiments. Equal numbers of sex matched SCID mice were injected s.c. ...
<p>NOD/SCID mice were subcutaneously injected with hPSC, ihPSC, and Hela cells (8 x 10<sup>6</sup> c...
<p>SCC-13 spheroid- and monolayer-derived cells were injected at 100 to 100,000 cells per each of tw...
<p>(A) 1×10<sup>3</sup> ABCG2<sup>hi</sup> SP and ABCG2<sup>low</sup> NSP sorted RT112 cells were su...
<p>Evaluation of the incidence of tumors in NOD/SCID mice implanted with different numbers of BCSCs ...
<p>(A) 1×10<sup>6</sup> ES cells (MPI-II) or <i>in vitro</i> differentiated cells (day 14 of differe...